Aurobindo Pharma Limited, a Hyderabad-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients (APIs), has received the final approval from the US Food and Drug Administration (USFDA) to manufacture and market Zaleplon capsules in 5mg and 10mg form.


</p><tr><td><p class='TableClas'></p><P class='TableClas'><DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>This is the company's 70th approval from the USFDA. </P>
</p><p class='TableClas'>Zaleplon capsules, the generic equivalent of King Pharmaceuticals' Sonata capsules, are indicated for the treatment of insomnia. </P>
</p><p class='TableClas'>Aurobindo is in the first line of generics and got the FDA nod on the very first day, post the expiry of the relevant patent, and has already launched the product in the US market, the company stated in a press release on Tuesday.&nbsp; <BR>&nbsp;</P></p><p class='TableClas'></p></table>


Aurobindo gets USFDA nod for Zaleplon capsules

More From This Section

Posco land acquisition resumes amid protests

Diageo to buy half of Mallya's South Africa beer biz

Average money spent for new players dips

'IndiGo did not comply with AAC guidelines'

Explore News